Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000056783 | SCV000336776 | likely pathogenic | not provided | 2016-03-07 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000817811 | SCV000958394 | pathogenic | Desmin-related myofibrillar myopathy | 2019-12-12 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change forms filaments and does not induce aggregation in cell lines (PMID: 23032110). This variant has been observed to segregate with autosomal dominant desminopathies in several families (PMID:17418574, 22153487, 22395865, 26431784). ClinVar contains an entry for this variant (Variation ID: 39718). This variant is not present in population databases (ExAC no frequency). This sequence change replaces proline with serine at codon 419 of the DES protein (p.Pro419Ser). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and serine. |
Neuberg Supratech Reference Laboratories Pvt Ltd, |
RCV000817811 | SCV004100543 | pathogenic | Desmin-related myofibrillar myopathy | criteria provided, single submitter | clinical testing | The missense variant p.P419S in DES (NM_001927.4) has been previously reported in multiple patients with autosomal dominant desminopathies (Olivé M et al,Wahbi K et al). Functional studies reveal a damaging effect (Brodehl A et al). The variant has been submitted to ClinVar as Pathogenic.The p.P419S variant is novel (not in any individuals) in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. There is a moderate physicochemical difference between proline and serine. The p.P419S missense variant is predicted to be damaging by both SIFT and PolyPhen2. The proline residue at codon 419 of DES is conserved in all mammalian species. The nucleotide c.1255 in DES is predicted conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Pathogenic. | |
OMIM | RCV000817811 | SCV000056695 | pathogenic | Desmin-related myofibrillar myopathy | 2012-09-01 | no assertion criteria provided | literature only | |
Epithelial Biology; Institute of Medical Biology, |
RCV000056783 | SCV000087896 | not provided | not provided | no assertion provided | not provided | ||
Department of Rehabilitation Medicine, |
RCV000817811 | SCV000882769 | pathogenic | Desmin-related myofibrillar myopathy | 2019-02-11 | no assertion criteria provided | research |